News S3-E34.1 – #ILC2022 Looking Back: Resmetirom Late-Breaker and Cirrhosis Study Jul 2, 2022 S3-E34 #ILC2022 Wrap-Up 1: NASH Drug Development Excitement! Jun 30, 2022 S3-E33 – Day 4 of ILC2022: Friendly Debates About NITs, PLUS Discussing the Patient Advocate’s Pers Jun 28, 2022 S3-E32 – Days 1-3 of ILC 2022: The Value of FIB-4 and In-Person Meetings Jun 27, 2022 S3-E30.4 – Highlighting Intriguing #ILC2022 Abstracts: Potential Uses of FIB-4 Jun 20, 2022 S3-E30.2 – Highlighting Intriguing #ILC2022 Abstracts: Elastography and the Importance of NAFLD Qua Jun 19, 2022 S3-E30.3 – Highlighting Intriguing #ILC2022 Abstracts: More on NAFLD Quality of Life Jun 19, 2022 S3-E30.3 – Highlighting Intriguing #ILC2022 Abstracts: More on NAFLD Quality of Life Jun 19, 2022 S3-E30.1 – Highlighting Intriguing #ILC2022 Abstracts: Machine Learning Identified NASH Biomarkers Jun 18, 2022 S3-E29.1 – #NASHDay 2022 Wrap-up Panel: What #NASHDay Means To Our Community In 2022 and Why It Mat Jun 13, 2022 S3-E28.4 – #NASHDay 2022 Preview: SurfingNASH Predictions Jun 13, 2022 S3-E29.2 – #NASHDay 2022 Wrap-Up Panel: The Importance of #StopNASHNow Jun 13, 2022 « Older Entries Next Entries »
S3-E33 – Day 4 of ILC2022: Friendly Debates About NITs, PLUS Discussing the Patient Advocate’s Pers Jun 28, 2022
S3-E30.2 – Highlighting Intriguing #ILC2022 Abstracts: Elastography and the Importance of NAFLD Qua Jun 19, 2022
S3-E30.1 – Highlighting Intriguing #ILC2022 Abstracts: Machine Learning Identified NASH Biomarkers Jun 18, 2022
S3-E29.1 – #NASHDay 2022 Wrap-up Panel: What #NASHDay Means To Our Community In 2022 and Why It Mat Jun 13, 2022